Trial · NCT07346235
150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial
NCT07346235, Phase 3, Withdrawn, American Hospital 2 Kosovo
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial. Trials, record NCT07346235. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07346235
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial
- NCT number
- NCT07346235
- Status
- Withdrawn
- Phases
- Phase 3
- Enrollment
- 0 participants, actual
- Lead sponsor
- American Hospital 2 Kosovo
- Conditions
- Infertility, Female
- Interventions
- Follicle-stimulating hormone (FSH), Follicle-stimulating hormone (FSH)
- First posted
- 2026-01-16
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative Live Birth Rate per Initiated Cycle | Up to 12 months after randomization | The delivery of at least one live-born infant at ≥24 weeks of gestation resulting from the first fresh embryo transfer or any subsequent frozen embryo transfer from a single stimulation cycle. |
| Secondary | Number of Oocytes Retrieved | Up to 2 weeks | Total number of oocytes retrieved at oocyte pick-up. |
| Secondary | Incidence of Moderate/Severe OHSS | Up to 4 weeks after oocyte retrieval | Proportion of participants developing moderate or severe OHSS according to Golan classification. |
| Secondary | Total FSH Consumption | Up to 2 weeks | Total amount of FSH (in IU) used during the stimulation cycle. |
| Secondary | Clinical Pregnancy Rate | 7 weeks of gestation | Presence of a gestational sac with fetal heartbeat on ultrasound at 7 weeks of gestation. |
| Secondary | Live Birth Rate per Transfer | Up to 12 months after randomization | Delivery of a live-born infant per embryo transfer procedure. |
| Secondary | Cycle Cancellation Rate | Up to 2 weeks | Proportion of cycles cancelled before oocyte retrieval. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 29121326 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07346235
GET https://conductscience.org/api/trials/v1/NCT07346235/registered